Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Franziska Mußbach"'
Autor:
Beate Richter, Constanze Sänger, Franziska Mussbach, Hubert Scheuerlein, Utz Settmacher, Uta Dahmen
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
Background and AimsPatients with malignant biliary obstruction do not seem to benefit from “two-stage hepatectomy” due to an impairment of liver regeneration. We designed a novel model of “repeated regeneration stimuli” in rats mimicking a
Externí odkaz:
https://doaj.org/article/f80cae21471b4995a363696af009c0ed
Autor:
Beate Richter, Constanze Sänger, Franziska Mussbach, Hubert Scheuerlein, Utz Settmacher, Uta Dahmen
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0271975 (2022)
BackgroundThe selection of the appropriate species is one of the key issues in experimental medicine. Bile duct ligation is the mostly used experimental model in rodents to explore special aspects of occlusive cholestasis. We aimed to clarify if rats
Externí odkaz:
https://doaj.org/article/ecdfd53b2cce4a969f2fc502941104cb
Autor:
Philipp Felgendreff, Claudia Schindler, Franziska Mussbach, Chichi Xie, Felix Gremse, Utz Settmacher, Uta Dahmen
Publikováno v:
Heliyon, Vol 7, Iss 2, Pp e06129- (2021)
Background: Biological organ engineering is a novel experimental approach to generate functional liver grafts by decellularization and repopulation. Currently, healthy organs of small or large animals and human organs with preexisting liver diseases
Externí odkaz:
https://doaj.org/article/5e003a203b484c8b86387010a3254394
Autor:
Daniel Kaemmerer, Robin Schindler, Franziska Mußbach, Uta Dahmen, Annelore Altendorf-Hofmann, Olaf Dirsch, Jörg Sänger, Stefan Schulz, Amelie Lupp
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient standard therapy is currently available. Recently, somatostatin analogs have been ev
Externí odkaz:
https://doaj.org/article/e54bffdf432d41d08ba56095de5a89a4
Autor:
Andrea-Anneliese Keller, Franziska Mussbach, Reinhard Breitling, Peter Hemmerich, Buerk Schaefer, Stefan Lorkowski, Siegmund Reissmann
Publikováno v:
Pharmaceuticals, Vol 6, Iss 2, Pp 184-203 (2013)
Modulating signaling pathways for research and therapy requires either suppression or expression of selected genes or internalization of proteins such as enzymes, antibodies, nucleotide binding proteins or substrates including nucleoside phosphates a
Externí odkaz:
https://doaj.org/article/2ae3b329f7d14aaeae08cb0c1b969b7f
Autor:
Beate, Richter, Constanze, Sänger, Franziska, Mussbach, Hubert, Scheuerlein, Utz, Settmacher, Uta, Dahmen
Publikováno v:
Innovative Surgical Sciences. 7:13-22
Background Modern therapy concepts are of limited success in patients with cholestasis (e.g., biliary occluding malignancies). Therefore, we established a new animal model enabling simultaneous investigation of liver regeneration and hepato-biliary r
Autor:
Beate, Richter, Constanze, Sänger, Franziska, Mussbach, Hubert, Scheuerlein, Utz, Settmacher, Uta, Dahmen
Publikováno v:
PloS one. 17(7)
The selection of the appropriate species is one of the key issues in experimental medicine. Bile duct ligation is the mostly used experimental model in rodents to explore special aspects of occlusive cholestasis. We aimed to clarify if rats or mice a
Autor:
Beate, Richter, Constanze, Sänger, Franziska, Mussbach, Hubert, Scheuerlein, Utz, Settmacher, Uta, Dahmen
Publikováno v:
Frontiers in surgery. 9
Patients with malignant biliary obstruction do not seem to benefit from "two-stage hepatectomy" due to an impairment of liver regeneration. We designed a novel model of "repeated regeneration stimuli" in rats mimicking a "two-stage hepatectomy" with
Autor:
Uta Dahmen, Jörg Sänger, Annelore Altendorf-Hofmann, Daniel Kaemmerer, Olaf Dirsch, Robin Schindler, Stefan Schulz, Amelie Lupp, Franziska Mußbach
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
BMC Cancer
BMC Cancer
Background Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient standard therapy is currently available. Recently, somatostatin analogs have been evaluated f
Autor:
Tonia Jeiter, Andreas Koops, Klaus Ulrich Klein, Chong Wha Baek, Romina H. Aspera-Werz, Stefan Fichtner-Feigl, Laurent Morax, Andreas K. Nussler, Ingeborg Friehs, Nils Heits, Simon P. Hoerstrup, Thomas Freude, Sabrina Ehnert, Ulrich Hahn, Marie K. Reumann, Druckerei Stückle, Lars Mueller, Chichi Xie, Anna Kathrin Hell, Roman Ullrich, Björn Gunnar Ochs, Felix Braun, Jochen Herrmann, Klaus Markstaller, Hong Qi, Hans S. Hofmann, Sonia Sippel, Si Ra Bang, Christian Wilms, Alexander Arlt, Christian Bahrs, Eun Jin Ahn, Thomas Becker, Young Cheol Woo, Petra Ruemmele, Hans J. Schlitt, Uta Dahmen, Geun Joo Choi, Colin C Schwarzwald, Benedikt Weber, Stefan Pscherer, Andrew Entwistle, Iyad Kabar, Laura Schwarz, Katharina Doerr, Katharyn J Mitchell, Franziska Mußbach, Stefan M. Brunner, Olaf Dirsch, Eva Verena Tretter, Zsolt Sziklavari, Sarah Koenig, Pedro J. del Nido, Shogo Shimada, Lourdes Soto-Gonzalez, Hyun Kang, Yong Hun Jung, Utz Settmacher, Christina Hafner, Rebecca Kesselring, Satz Mengensatzproduktion, Susan Koops, Elke Wintermeyer, Christoph Rubner, Agnieszka A. Książek, Alexander Hendricks, Steffen Schröter
Publikováno v:
European Surgical Research. 57:I-IV